CRISTOFERI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 2.690
EU - Europa 1.752
AS - Asia 367
SA - Sud America 7
AF - Africa 3
Totale 4.819
Nazione #
US - Stati Uniti d'America 2.676
IT - Italia 537
DE - Germania 357
SE - Svezia 331
IE - Irlanda 254
CN - Cina 137
GB - Regno Unito 133
HK - Hong Kong 110
IN - India 36
VN - Vietnam 31
FI - Finlandia 21
DK - Danimarca 20
FR - Francia 20
UA - Ucraina 17
MY - Malesia 16
CA - Canada 14
RU - Federazione Russa 14
BE - Belgio 12
NL - Olanda 10
TR - Turchia 10
AT - Austria 8
IL - Israele 7
ES - Italia 6
BR - Brasile 5
MM - Myanmar 4
TW - Taiwan 4
IQ - Iraq 3
NO - Norvegia 3
CH - Svizzera 2
GH - Ghana 2
GR - Grecia 2
IR - Iran 2
JP - Giappone 2
PK - Pakistan 2
AR - Argentina 1
BG - Bulgaria 1
EC - Ecuador 1
EE - Estonia 1
KR - Corea 1
LK - Sri Lanka 1
LT - Lituania 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
Totale 4.819
Città #
Ann Arbor 862
Frankfurt am Main 327
Dublin 242
Fairfield 231
Chandler 218
Wilmington 178
Milan 175
New York 118
Ashburn 113
Hong Kong 104
Woodbridge 104
Seattle 85
Houston 84
London 83
Cambridge 81
Princeton 72
Shanghai 46
Dearborn 44
Chicago 36
Lawrence 35
Altamura 28
Rome 26
Beijing 24
Boardman 21
San Diego 20
Pune 17
Helsinki 16
Penang 16
Nanjing 15
Jacksonville 13
Los Angeles 13
Monza 13
Andover 12
Brussels 11
Turin 10
Mumbai 8
Bologna 7
Fremont 7
Guangzhou 7
Central 6
Detroit 6
Kocaeli 6
Lissone 6
Padova 6
Cagliari 5
Genoa 5
Modena 5
Naples 5
Toronto 5
Vienna 5
Appiano Gentile 4
Castiglione del Lago 4
Council Bluffs 4
Dong Ket 4
Jiaxing 4
Jinan 4
Lappeenranta 4
Norwalk 4
Shenyang 4
Udine 4
Carate Brianza 3
Changsha 3
Chioggia 3
Comazzo 3
Cossato 3
Edmonton 3
Falls Church 3
Florence 3
Garbagnate Milanese 3
Giv‘at Shmuel 3
Hangzhou 3
Hebei 3
Hounslow 3
Huizen 3
Kilburn 3
Kunming 3
Lodi 3
Moscow 3
New Taipei 3
Paris 3
São Paulo 3
Terni 3
Vigevano 3
Washington 3
Wuhan 3
Accra 2
Acquaviva delle Fonti 2
Agrate Brianza 2
Athens 2
Atripalda 2
Baniapur 2
Bari 2
Bergamo 2
Bettona 2
Buffalo 2
Castano Primo 2
Castelnuovo Scrivia 2
Catania 2
Cinisello 2
Dongguan 2
Totale 3.727
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 399
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 212
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 192
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 182
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 169
Precision medicine in primary biliary cholangitis 167
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 159
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 155
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 153
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 150
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 147
New Therapeutic Targets in Autoimmune Cholangiopathies 140
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 134
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 133
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 129
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 123
Prognostic models in primary biliary cholangitis 122
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 119
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 113
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 113
The immunobiology of female predominance in primary biliary cholangitis 111
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 106
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 105
Risk stratification in primary sclerosing cholangitis 97
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 89
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 87
Endocrinology and Metabolic Diseases (Including Diabetes) 85
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 83
Fibrocystic liver disease 83
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 72
A Smooth Esophageal Stricture Causing Dysphagia 71
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 71
Individualizing Care: Management Beyond Medical Therapy 69
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 67
Antioxidant treatment for acute pancreatitis 59
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 54
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 54
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 51
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 49
Transient elastography in chronic liver disease: beware to the cut-offs! 43
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 40
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 40
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 34
Artificial intelligence for precision medicine in autoimmune liver disease 33
An update on novel pharmacological agents for primary sclerosing cholangitis 33
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 33
X marks the spot in autoimmunity 29
The Role of Epigenetics in Primary Biliary Cholangitis 27
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 25
Systematic review-Pancreatic involvement in inflammatory bowel disease 24
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 22
Elastography in Autoimmune Liver Diseases 22
Primary Sclerosing Cholangitis 21
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 20
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 13
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 4
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 3
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 3
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 3
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 3
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 3
Totale 5.152
Categoria #
all - tutte 19.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201959 0 0 0 0 0 0 0 0 0 0 27 32
2019/2020607 29 48 30 49 61 65 80 59 59 69 42 16
2020/20211.133 29 25 184 66 88 121 101 130 89 78 115 107
2021/2022772 100 98 140 80 43 41 14 42 39 32 53 90
2022/20231.413 118 329 125 93 134 177 108 69 99 47 74 40
2023/20241.079 44 65 67 129 144 258 175 28 67 98 4 0
Totale 5.152